Notice: TimeXNet Web will be temporarily affected due to Human Genome Center server maintenance until February 21 (Wednesday) 09:00 JST.
Job Name:
LPS Response in Mouse MyD88 KO BMDCs
Current Gene List:
Background List:
Whole Genome
Note: Only the top 1000 records are shown here
| Category | Term | Genes | Count | % | P-value | Benjamini |
|---|---|---|---|---|---|---|
| KEGG_PATHWAY | mmu05161:Hepatitis B | 63 | 7.9 | 3.6e-32 | 8.5e-30 | |
| KEGG_PATHWAY | mmu05142:Chagas disease (American trypanosomiasis) | 53 | 6.6 | 1.0e-31 | 1.2e-29 | |
| KEGG_PATHWAY | mmu04660:T cell receptor signaling pathway | 51 | 6.4 | 3.2e-29 | 2.5e-27 | |
| KEGG_PATHWAY | mmu05200:Pathways in cancer | 101 | 12.6 | 3.3e-29 | 2.0e-27 | |
| KEGG_PATHWAY | mmu04071:Sphingolipid signaling pathway | 54 | 6.8 | 9.0e-28 | 4.3e-26 | |
| KEGG_PATHWAY | mmu04210:Apoptosis | 37 | 4.6 | 9.0e-26 | 3.6e-24 | |
| KEGG_PATHWAY | mmu05220:Chronic myeloid leukemia | 40 | 5.0 | 1.6e-25 | 5.4e-24 | |
| KEGG_PATHWAY | mmu05160:Hepatitis C | 54 | 6.8 | 2.0e-25 | 5.9e-24 | |
| KEGG_PATHWAY | mmu04722:Neurotrophin signaling pathway | 51 | 6.4 | 3.1e-25 | 8.2e-24 | |
| KEGG_PATHWAY | mmu04012:ErbB signaling pathway | 43 | 5.4 | 8.6e-25 | 2.1e-23 | |
| KEGG_PATHWAY | mmu05215:Prostate cancer | 43 | 5.4 | 1.5e-24 | 3.3e-23 | |
| KEGG_PATHWAY | mmu05222:Small cell lung cancer | 42 | 5.2 | 1.8e-24 | 3.6e-23 | |
| KEGG_PATHWAY | mmu04917:Prolactin signaling pathway | 39 | 4.9 | 4.6e-24 | 8.5e-23 | |
| KEGG_PATHWAY | mmu05169:Epstein-Barr virus infection | 66 | 8.2 | 9.2e-24 | 1.6e-22 | |
| KEGG_PATHWAY | mmu05162:Measles | 52 | 6.5 | 1.3e-23 | 2.1e-22 | |
| KEGG_PATHWAY | mmu04068:FoxO signaling pathway | 51 | 6.4 | 4.9e-23 | 7.2e-22 | |
| KEGG_PATHWAY | mmu04151:PI3K-Akt signaling pathway | 85 | 10.6 | 6.7e-23 | 9.3e-22 | |
| KEGG_PATHWAY | mmu05212:Pancreatic cancer | 36 | 4.5 | 6.7e-23 | 8.9e-22 | |
| KEGG_PATHWAY | mmu04664:Fc epsilon RI signaling pathway | 35 | 4.4 | 6.6e-21 | 8.2e-20 | |
| KEGG_PATHWAY | mmu04620:Toll-like receptor signaling pathway | 42 | 5.2 | 1.1e-20 | 1.3e-19 | |
| KEGG_PATHWAY | mmu05145:Toxoplasmosis | 44 | 5.5 | 2.4e-20 | 2.7e-19 | |
| KEGG_PATHWAY | mmu04066:HIF-1 signaling pathway | 42 | 5.2 | 4.0e-20 | 4.3e-19 | |
| KEGG_PATHWAY | mmu05210:Colorectal cancer | 33 | 4.1 | 9.5e-20 | 9.8e-19 | |
| KEGG_PATHWAY | mmu04370:VEGF signaling pathway | 32 | 4.0 | 1.0e-19 | 1.0e-18 | |
| KEGG_PATHWAY | mmu05223:Non-small cell lung cancer | 31 | 3.9 | 1.0e-19 | 9.9e-19 | |
| KEGG_PATHWAY | mmu04910:Insulin signaling pathway | 48 | 6.0 | 1.6e-19 | 1.5e-18 | |
| KEGG_PATHWAY | mmu04662:B cell receptor signaling pathway | 34 | 4.2 | 2.6e-19 | 2.3e-18 | |
| KEGG_PATHWAY | mmu05205:Proteoglycans in cancer | 58 | 7.2 | 3.1e-19 | 2.6e-18 | |
| KEGG_PATHWAY | mmu05213:Endometrial cancer | 29 | 3.6 | 1.5e-18 | 1.2e-17 | |
| KEGG_PATHWAY | mmu05166:HTLV-I infection | 68 | 8.5 | 1.5e-18 | 1.2e-17 | |
| KEGG_PATHWAY | mmu04668:TNF signaling pathway | 41 | 5.1 | 2.4e-18 | 1.8e-17 | |
| KEGG_PATHWAY | mmu04510:Focal adhesion | 57 | 7.1 | 4.3e-18 | 3.2e-17 | |
| KEGG_PATHWAY | mmu04932:Non-alcoholic fatty liver disease (NAFLD) | 49 | 6.1 | 5.2e-18 | 3.7e-17 | |
| KEGG_PATHWAY | mmu04064:NF-kappa B signaling pathway | 38 | 4.8 | 1.0e-17 | 7.2e-17 | |
| KEGG_PATHWAY | mmu05221:Acute myeloid leukemia | 29 | 3.6 | 2.0e-17 | 1.3e-16 | |
| KEGG_PATHWAY | mmu05214:Glioma | 31 | 3.9 | 2.4e-17 | 1.6e-16 | |
| KEGG_PATHWAY | mmu05164:Influenza A | 50 | 6.2 | 4.5e-17 | 2.9e-16 | |
| KEGG_PATHWAY | mmu05231:Choline metabolism in cancer | 38 | 4.8 | 4.9e-17 | 3.1e-16 | |
| KEGG_PATHWAY | mmu04919:Thyroid hormone signaling pathway | 40 | 5.0 | 7.4e-17 | 6.7e-16 | |
| KEGG_PATHWAY | mmu04062:Chemokine signaling pathway | 53 | 6.6 | 1.7e-16 | 1.3e-15 | |
| KEGG_PATHWAY | mmu04152:AMPK signaling pathway | 42 | 5.2 | 1.7e-16 | 1.3e-15 | |
| KEGG_PATHWAY | mmu04931:Insulin resistance | 39 | 4.9 | 1.8e-16 | 1.2e-15 | |
| KEGG_PATHWAY | mmu05203:Viral carcinogenesis | 58 | 7.2 | 3.2e-16 | 1.9e-15 | |
| KEGG_PATHWAY | mmu04014:Ras signaling pathway | 57 | 7.1 | 8.0e-16 | 4.2e-15 | |
| KEGG_PATHWAY | mmu04380:Osteoclast differentiation | 41 | 5.1 | 9.0e-16 | 4.7e-15 | |
| KEGG_PATHWAY | mmu04630:Jak-STAT signaling pathway | 44 | 5.5 | 1.2e-15 | 6.3e-15 | |
| KEGG_PATHWAY | mmu04666:Fc gamma R-mediated phagocytosis | 33 | 4.1 | 2.0e-15 | 1.0e-14 | |
| KEGG_PATHWAY | mmu04010:MAPK signaling pathway | 59 | 7.4 | 5.1e-15 | 2.5e-14 | |
| KEGG_PATHWAY | mmu05211:Renal cell carcinoma | 29 | 3.6 | 7.3e-15 | 3.6e-14 | |
| KEGG_PATHWAY | mmu04650:Natural killer cell mediated cytotoxicity | 36 | 4.5 | 1.2e-14 | 5.6e-14 | |
| KEGG_PATHWAY | mmu04930:Type II diabetes mellitus | 25 | 3.1 | 1.4e-14 | 6.6e-14 | |
| KEGG_PATHWAY | mmu05230:Central carbon metabolism in cancer | 28 | 3.5 | 1.7e-14 | 7.8e-14 | |
| KEGG_PATHWAY | mmu04015:Rap1 signaling pathway | 51 | 6.4 | 2.0e-13 | 9.0e-13 | |
| KEGG_PATHWAY | mmu05168:Herpes simplex infection | 50 | 6.2 | 2.5e-13 | 1.1e-12 | |
| KEGG_PATHWAY | mmu04914:Progesterone-mediated oocyte maturation | 31 | 3.9 | 3.5e-13 | 1.5e-12 | |
| KEGG_PATHWAY | mmu05133:Pertussis | 28 | 3.5 | 1.1e-12 | 4.8e-12 | |
| KEGG_PATHWAY | mmu05152:Tuberculosis | 44 | 5.5 | 2.1e-12 | 8.8e-12 | |
| KEGG_PATHWAY | mmu04621:NOD-like receptor signaling pathway | 24 | 3.0 | 3.0e-12 | 1.2e-11 | |
| KEGG_PATHWAY | mmu04150:mTOR signaling pathway | 24 | 3.0 | 1.1e-11 | 4.5e-11 | |
| KEGG_PATHWAY | mmu04915:Estrogen signaling pathway | 31 | 3.9 | 1.1e-11 | 4.5e-11 | |
| KEGG_PATHWAY | mmu04611:Platelet activation | 36 | 4.5 | 1.7e-11 | 6.6e-11 | |
| KEGG_PATHWAY | mmu05100:Bacterial invasion of epithelial cells | 27 | 3.4 | 3.2e-11 | 1.2e-10 | |
| KEGG_PATHWAY | mmu04810:Regulation of actin cytoskeleton | 47 | 5.9 | 4.3e-11 | 1.6e-10 | |
| KEGG_PATHWAY | mmu04622:RIG-I-like receptor signaling pathway | 25 | 3.1 | 4.7e-11 | 1.8e-10 | |
| KEGG_PATHWAY | mmu04261:Adrenergic signaling in cardiomyocytes | 38 | 4.8 | 5.7e-11 | 2.1e-10 | |
| KEGG_PATHWAY | mmu04670:Leukocyte transendothelial migration | 33 | 4.1 | 1.7e-10 | 6.1e-10 | |
| KEGG_PATHWAY | mmu04144:Endocytosis | 53 | 6.6 | 5.1e-10 | 1.8e-9 | |
| KEGG_PATHWAY | mmu05010:Alzheimer's disease | 40 | 5.0 | 6.4e-10 | 2.2e-9 | |
| KEGG_PATHWAY | mmu04728:Dopaminergic synapse | 34 | 4.2 | 6.7e-10 | 2.3e-9 | |
| KEGG_PATHWAY | mmu04120:Ubiquitin mediated proteolysis | 35 | 4.4 | 8.2e-10 | 2.8e-9 | |
| KEGG_PATHWAY | mmu05218:Melanoma | 24 | 3.0 | 8.6e-10 | 2.9e-9 | |
| KEGG_PATHWAY | mmu04520:Adherens junction | 24 | 3.0 | 1.2e-9 | 3.9e-9 | |
| KEGG_PATHWAY | mmu04114:Oocyte meiosis | 30 | 3.8 | 1.3e-9 | 4.4e-9 | |
| KEGG_PATHWAY | mmu04920:Adipocytokine signaling pathway | 23 | 2.9 | 6.9e-9 | 2.2e-8 | |
| KEGG_PATHWAY | mmu04530:Tight junction | 33 | 4.1 | 7.4e-9 | 2.3e-8 | |
| KEGG_PATHWAY | mmu04960:Aldosterone-regulated sodium reabsorption | 17 | 2.1 | 1.0e-8 | 3.3e-8 | |
| KEGG_PATHWAY | mmu04024:cAMP signaling pathway | 40 | 5.0 | 1.6e-8 | 5.0e-8 | |
| KEGG_PATHWAY | mmu04110:Cell cycle | 30 | 3.8 | 2.6e-8 | 7.9e-8 | |
| KEGG_PATHWAY | mmu04390:Hippo signaling pathway | 33 | 4.1 | 6.1e-8 | 1.8e-7 | |
| KEGG_PATHWAY | mmu05134:Legionellosis | 19 | 2.4 | 9.4e-8 | 2.8e-7 | |
| KEGG_PATHWAY | mmu05012:Parkinson's disease | 32 | 4.0 | 1.5e-7 | 4.5e-7 | |
| KEGG_PATHWAY | mmu04141:Protein processing in endoplasmic reticulum | 34 | 4.2 | 2.5e-7 | 7.4e-7 | |
| KEGG_PATHWAY | mmu04022:cGMP-PKG signaling pathway | 34 | 4.2 | 3.9e-7 | 1.1e-6 | |
| KEGG_PATHWAY | mmu05016:Huntington's disease | 37 | 4.6 | 5.4e-7 | 1.5e-6 | |
| KEGG_PATHWAY | mmu04923:Regulation of lipolysis in adipocytes | 18 | 2.2 | 5.4e-7 | 1.5e-6 | |
| KEGG_PATHWAY | mmu05014:Amyotrophic lateral sclerosis (ALS) | 17 | 2.1 | 5.4e-7 | 1.5e-6 | |
| KEGG_PATHWAY | mmu05140:Leishmaniasis | 19 | 2.4 | 6.6e-7 | 1.8e-6 | |
| KEGG_PATHWAY | mmu04550:Signaling pathways regulating pluripotency of stem cells | 29 | 3.6 | 1.1e-6 | 2.8e-6 | |
| KEGG_PATHWAY | mmu04921:Oxytocin signaling pathway | 31 | 3.9 | 1.9e-6 | 5.1e-6 | |
| KEGG_PATHWAY | mmu04350:TGF-beta signaling pathway | 21 | 2.6 | 3.5e-6 | 9.2e-6 | |
| KEGG_PATHWAY | mmu05146:Amoebiasis | 25 | 3.1 | 5.1e-6 | 1.3e-5 | |
| KEGG_PATHWAY | mmu05202:Transcriptional misregulation in cancer | 31 | 3.9 | 5.4e-6 | 1.4e-5 | |
| KEGG_PATHWAY | mmu05219:Bladder cancer | 14 | 1.8 | 5.6e-6 | 1.4e-5 | |
| KEGG_PATHWAY | mmu04115:p53 signaling pathway | 18 | 2.2 | 6.4e-6 | 1.6e-5 | |
| KEGG_PATHWAY | mmu05132:Salmonella infection | 19 | 2.4 | 1.4e-5 | 3.6e-5 | |
| KEGG_PATHWAY | mmu05206:MicroRNAs in cancer | 41 | 5.1 | 4.2e-5 | 0.0001 | |
| KEGG_PATHWAY | mmu04310:Wnt signaling pathway | 26 | 3.2 | 4.6e-5 | 0.00011 | |
| KEGG_PATHWAY | mmu04750:Inflammatory mediator regulation of TRP channels | 24 | 3.0 | 5.7e-5 | 0.00014 | |
| KEGG_PATHWAY | mmu04912:GnRH signaling pathway | 19 | 2.4 | 8.0e-5 | 0.00019 | |
| KEGG_PATHWAY | mmu05340:Primary immunodeficiency | 11 | 1.4 | 0.00014 | 0.00033 | |
| KEGG_PATHWAY | mmu04973:Carbohydrate digestion and absorption | 12 | 1.5 | 0.0002 | 0.00048 | |
| KEGG_PATHWAY | mmu03015:mRNA surveillance pathway | 19 | 2.4 | 0.00026 | 0.0006 | |
| KEGG_PATHWAY | mmu05416:Viral myocarditis | 16 | 2.0 | 0.00071 | 0.0016 | |
| KEGG_PATHWAY | mmu04725:Cholinergic synapse | 20 | 2.5 | 0.00073 | 0.0017 | |
| KEGG_PATHWAY | mmu04070:Phosphatidylinositol signaling system | 18 | 2.2 | 0.00085 | 0.0019 | |
| KEGG_PATHWAY | mmu05216:Thyroid cancer | 9 | 1.1 | 0.001 | 0.0023 | |
| KEGG_PATHWAY | mmu04720:Long-term potentiation | 14 | 1.8 | 0.0011 | 0.0025 | |
| KEGG_PATHWAY | mmu04360:Axon guidance | 21 | 2.6 | 0.0015 | 0.0033 | |
| KEGG_PATHWAY | mmu04710:Circadian rhythm | 9 | 1.1 | 0.0017 | 0.0037 | |
| KEGG_PATHWAY | mmu04730:Long-term depression | 13 | 1.6 | 0.0017 | 0.0038 | |
| KEGG_PATHWAY | mmu04623:Cytosolic DNA-sensing pathway | 13 | 1.6 | 0.0027 | 0.0057 | |
| KEGG_PATHWAY | mmu04540:Gap junction | 15 | 1.9 | 0.0048 | 0.01 | |
| KEGG_PATHWAY | mmu00190:Oxidative phosphorylation | 20 | 2.5 | 0.0081 | 0.017 | |
| KEGG_PATHWAY | mmu05020:Prion diseases | 8 | 1.0 | 0.0086 | 0.018 | |
| KEGG_PATHWAY | mmu04640:Hematopoietic cell lineage | 14 | 1.8 | 0.0098 | 0.02 | |
| KEGG_PATHWAY | mmu00220:Arginine biosynthesis | 6 | 0.8 | 0.012 | 0.024 | |
| KEGG_PATHWAY | mmu05321:Inflammatory bowel disease (IBD) | 11 | 1.4 | 0.012 | 0.024 | |
| KEGG_PATHWAY | mmu04961:Endocrine and other factor-regulated calcium reabsorption | 10 | 1.2 | 0.015 | 0.03 | |
| KEGG_PATHWAY | mmu04721:Synaptic vesicle cycle | 11 | 1.4 | 0.017 | 0.033 | |
| KEGG_PATHWAY | mmu03050:Proteasome | 9 | 1.1 | 0.018 | 0.035 | |
| KEGG_PATHWAY | mmu04142:Lysosome | 17 | 2.1 | 0.021 | 0.04 | |
| KEGG_PATHWAY | mmu05031:Amphetamine addiction | 11 | 1.4 | 0.028 | 0.053 | |
| KEGG_PATHWAY | mmu05030:Cocaine addiction | 9 | 1.1 | 0.029 | 0.055 | |
| KEGG_PATHWAY | mmu04340:Hedgehog signaling pathway | 6 | 0.8 | 0.031 | 0.058 | |
| KEGG_PATHWAY | mmu04320:Dorso-ventral axis formation | 6 | 0.8 | 0.036 | 0.068 | |
| KEGG_PATHWAY | mmu00562:Inositol phosphate metabolism | 11 | 1.4 | 0.036 | 0.068 | |
| KEGG_PATHWAY | mmu05034:Alcoholism | 23 | 2.9 | 0.051 | 0.094 | |
| KEGG_PATHWAY | mmu04020:Calcium signaling pathway | 21 | 2.6 | 0.052 | 0.094 | |
| KEGG_PATHWAY | mmu04145:Phagosome | 20 | 2.5 | 0.065 | 0.12 | |
| KEGG_PATHWAY | mmu04612:Antigen processing and presentation | 11 | 1.4 | 0.088 | 0.16 | |
| KEGG_PATHWAY | mmu04724:Glutamatergic synapse | 14 | 1.8 | 0.092 | 0.16 |